2WQ-27719-13342
2 vaccinations
3 coded responses
4 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 761 / TX
- Registered
- 2021-06-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-26
Dose 1 — Pfizer-BioNTech
-
2021-04-23
Dose 2 — Pfizer-BioNTech
-
2021-06-08
Registered in v-safe
-
2021-06-08
Survey response — day 42, dose 2MedDRA: Cerebrovascular accident — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Stroke on April 26MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-08
Report sent to call center — day 42, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-23
Survey response — 3 months, dose 2MedDRA: Cardiac disorder, Cerebrovascular accident — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Stroke 4/26 and heart issuesMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-23
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-30
- 2021-08-02
- 2021-10-23
-
2022-04-23
Survey response — 12 months, dose 2MedDRA: Cardiac operation, Seizure — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: I have a seizure and heart surgery. · Healthcare visit (other): Heart surgeryMedDRA releases: 2024-11 · check-in free text available
-
2022-04-23
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
-
2022-04-25
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-26 | Pfizer-BioNTech | |
| 2 | 2021-04-23 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-08 | Successful | Participant prefers to complete VAERS report online |
| 2021-07-23 | Successful | Participant prefers to complete VAERS report online |
| 2022-04-23 | Successful 2022-04-25 |
Participant prefers to complete VAERS report online |
Free text
Release 8 — day 42, dose 2
Symptoms: Stroke on April 26
Release 9 — 3 months, dose 2
Symptoms: Stroke 4/26 and heart issues
Release 11 — 12 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Cardiac operation | · | · | ✓ |
| SD | Cardiac disorder | ✓ | · | ✓ |
| SD | Cardiac operation | · | · | ✓ |
| SD | Cerebrovascular accident | ✓ | ✓ | ✓ |
| SD | Seizure | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release